Biolligence
Biolligence helps biopharma companies design safer, faster clinical trials by predicting human-specific drug toxicity and efficacy. It uses population-based, human-relevant data and AI models to provide explainable insights that reveal safety liabilities early in development. The platform combines AI-driven analytics with a focus on toxicity mechanisms to support precise decision-making for clinical trial design. Category-wise, Biolligence operates as a B2B SaaS platform for pharma and biotech teams, integrating into existing R&D workflows to accelerate medicine development. By reducing animal testing and improving prediction accuracy, it aims to speed drug programs, lower costs, and deliver safer, more effective therapies at scale.
Biolligence
Biolligence helps biopharma companies design safer, faster clinical trials by predicting human-specific drug toxicity and efficacy. It uses population-based, human-relevant data and AI models to provide explainable insights that reveal safety liabilities early in development. The platform combines AI-driven analytics with a focus on toxicity mechanisms to support precise decision-making for clinical trial design. Category-wise, Biolligence operates as a B2B SaaS platform for pharma and biotech teams, integrating into existing R&D workflows to accelerate medicine development. By reducing animal testing and improving prediction accuracy, it aims to speed drug programs, lower costs, and deliver safer, more effective therapies at scale.